Of these 37 million people, up to 95% have type 2 diabetes [3]
An alternative mechanistic paradigm for the electrochemical C-terminal decarboxylation of peptides
The physiochemical properties of peptides make them particularly difficult to absorb into systemic circulation, although advancements in peptide chemistry aim to lower the threshold for viable oral bioavailability through increasing potency and extending half-lives
Lipedema and GLP-1: What Works and What Doesnt Heres the real breakdown no marketing, no false hope: What GLP-1s can help with Mobility and endurance Pain sensitivity driven by inflammation Joint loading from weight reduction Emotional health around eating control Prevention of obesity-related diseases What GLP-1s cannot reliably fix Cankles caused by lipedema tissue Nodules and fibrotic bands Hormonal triggers of progression Heaviness and tenderness in the legs Body disproportions that worsen emotional stress Many women report the same pattern: I lost weight everywhere except my legs. Thats not failure thats the biology of lipedema
The AR NTD is constitutively active in the absence of the LBD and thus can promote androgen depletion-resistant growth 138,153
CVOT trial will help determine if tirzepatide can demonstrate superior cardiovascular safety and potential additional cardiovascular benefits compared to the currently approved GLP-1RA dulaglutide